Myelodysplastic Syndrome Patient-Derived Xenografts: From No Options to Many

Haematologica - Italy
doi 10.3324/haematol.2019.233320
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Establishment of Patient-Derived Xenografts in Mice

BIO-PROTOCOL
2016English

P1.04-08 Co-Residence of Patient-Derived Immune Cells in Patient-Derived Xenografts From Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Patient-Derived Breast Tumor Xenografts Facilitating Personalized Cancer Therapy

Breast Cancer Research
Cancer ResearchOncology
2013English

Computational Approach to Discriminate Human and Mouse Sequences in Patient-Derived Tumour Xenografts

BMC Genomics
BiotechnologyGenetics
2018English

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma

Cancers
Cancer ResearchOncology
2020English

Patient-Derived Tumor Xenografts: Transforming Clinical Samples Into Mouse Models

Cancer Research
Cancer ResearchOncology
2013English

Cryptic 5q Deletion in a Patient With Myelodysplastic Syndrome

British Journal of Haematology
Hematology
2017English

Mitral Valve Repair in a Patient With Myelodysplastic Syndrome

Annals of Thoracic and Cardiovascular Surgery
GastroenterologyCardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2011English

Pharmacological Inhibition of P38 MAPK Reduces Tumor Growth in Patient-Derived Xenografts From Colon Tumors

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy